Six new public issues, including Mahamaya Lifesciences, Shining Tools, Curis Lifesciences, Finance Buddha, and Shreeji Global FMCG, are set to launch on Dalal Street this week, collectively targeting over ₹10,700 crore. Market analysts highlight that these listings span healthcare, fintech, and consumer sectors, reflecting diversified investor opportunities. Subscription trends, pricing, and valuation multiples will be closely watched by investors. These IPOs are expected to gauge market sentiment, especially amid current equity trends and retail participation. Experts emphasize careful assessment of fundamentals and growth prospects before investing.